163 related articles for article (PubMed ID: 25423013)
21. Association of IKZF1 and CDKN2A gene polymorphisms with childhood acute lymphoblastic leukemia: a high-resolution melting analysis.
Sattarzadeh Bardsiri M; Zehtab S; Karami N; Farsinejad A; Ehsan M; Fatemi A
BMC Med Genomics; 2022 Aug; 15(1):171. PubMed ID: 35932035
[TBL] [Abstract][Full Text] [Related]
22. ARID5B, IKZF1 and non-genetic factors in the etiology of childhood acute lymphoblastic leukemia: the ESCALE study.
Rudant J; Orsi L; Bonaventure A; Goujon-Bellec S; Baruchel A; Petit A; Bertrand Y; Nelken B; Pasquet M; Michel G; Saumet L; Chastagner P; Ducassou S; Réguerre Y; Hémon D; Clavel J
PLoS One; 2015; 10(3):e0121348. PubMed ID: 25806972
[TBL] [Abstract][Full Text] [Related]
23. Association between CEBPE Variant and Childhood Acute Leukemia Risk: Evidence from a Meta-Analysis of 22 Studies.
Sun J; Zheng J; Tang L; Healy J; Sinnett D; Dai YE
PLoS One; 2015; 10(5):e0125657. PubMed ID: 25938438
[TBL] [Abstract][Full Text] [Related]
24. Association of genetic variation in IKZF1, ARID5B, and CEBPE and surrogates for early-life infections with the risk of acute lymphoblastic leukemia in Hispanic children.
Hsu LI; Chokkalingam AP; Briggs FB; Walsh K; Crouse V; Fu C; Metayer C; Wiemels JL; Barcellos LF; Buffler PA
Cancer Causes Control; 2015 Apr; 26(4):609-19. PubMed ID: 25761407
[TBL] [Abstract][Full Text] [Related]
25. MDR1 C3435T polymorphism and childhood acute lymphoblastic leukemia susceptibility: an updated meta-analysis.
Yue Q; Xiong B; Chen L; Chen Y; Bu F; Liu X; Cheng F
Biomed Pharmacother; 2015 Feb; 69():76-81. PubMed ID: 25661341
[TBL] [Abstract][Full Text] [Related]
26. Prognostic significance of IKZF1 deletion in adult B cell acute lymphoblastic leukemia: a meta-analysis.
Zhang W; Kuang P; Li H; Wang F; Wang Y
Ann Hematol; 2017 Feb; 96(2):215-225. PubMed ID: 27815723
[TBL] [Abstract][Full Text] [Related]
27. IKZF1 (Ikaros) deletions in BCR-ABL1-positive acute lymphoblastic leukemia are associated with short disease-free survival and high rate of cumulative incidence of relapse: a GIMEMA AL WP report.
Martinelli G; Iacobucci I; Storlazzi CT; Vignetti M; Paoloni F; Cilloni D; Soverini S; Vitale A; Chiaretti S; Cimino G; Papayannidis C; Paolini S; Elia L; Fazi P; Meloni G; Amadori S; Saglio G; Pane F; Baccarani M; Foà R
J Clin Oncol; 2009 Nov; 27(31):5202-7. PubMed ID: 19770381
[TBL] [Abstract][Full Text] [Related]
28. CEBPE polymorphism confers an increased risk of childhood acute lymphoblastic leukemia: a meta-analysis of 11 case-control studies with 5,639 cases and 10,036 controls.
Wang C; Chen J; Sun H; Sun L; Liu Y
Ann Hematol; 2015 Feb; 94(2):181-5. PubMed ID: 25195121
[TBL] [Abstract][Full Text] [Related]
29. Ikaros (IKZF1) alterations and minimal residual disease at day 15 assessed by flow cytometry predict prognosis of childhood BCR/ABL-negative acute lymphoblastic leukemia.
Volejnikova J; Mejstrikova E; Dörge P; Meissner B; Zimmermannova O; Svojgr K; Stanulla M; Cario G; Schrappe M; Stary J; Hrusak O; Trka J; Fronkova E
Pediatr Blood Cancer; 2013 Mar; 60(3):420-7. PubMed ID: 22997141
[TBL] [Abstract][Full Text] [Related]
30. ARID5B and IKZF1 variants, selected demographic factors, and childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group.
Linabery AM; Blommer CN; Spector LG; Davies SM; Robison LL; Ross JA
Leuk Res; 2013 Aug; 37(8):936-42. PubMed ID: 23692655
[TBL] [Abstract][Full Text] [Related]
31. Prognostic value of rare IKZF1 deletion in childhood B-cell precursor acute lymphoblastic leukemia: an international collaborative study.
Boer JM; van der Veer A; Rizopoulos D; Fiocco M; Sonneveld E; de Groot-Kruseman HA; Kuiper RP; Hoogerbrugge P; Horstmann M; Zaliova M; Palmi C; Trka J; Fronkova E; Emerenciano M; do Socorro Pombo-de-Oliveira M; Mlynarski W; Szczepanski T; Nebral K; Attarbaschi A; Venn N; Sutton R; Schwab CJ; Enshaei A; Vora A; Stanulla M; Schrappe M; Cazzaniga G; Conter V; Zimmermann M; Moorman AV; Pieters R; den Boer ML
Leukemia; 2016 Jan; 30(1):32-8. PubMed ID: 26202931
[TBL] [Abstract][Full Text] [Related]
32. IKZF1 deletion is an independent prognostic marker in childhood B-cell precursor acute lymphoblastic leukemia, and distinguishes patients benefiting from pulses during maintenance therapy: results of the EORTC Children's Leukemia Group study 58951.
Clappier E; Grardel N; Bakkus M; Rapion J; De Moerloose B; Kastner P; Caye A; Vivent J; Costa V; Ferster A; Lutz P; Mazingue F; Millot F; Plantaz D; Plat G; Plouvier E; Poirée M; Sirvent N; Uyttebroeck A; Yakouben K; Girard S; Dastugue N; Suciu S; Benoit Y; Bertrand Y; Cavé H;
Leukemia; 2015 Nov; 29(11):2154-61. PubMed ID: 26050650
[TBL] [Abstract][Full Text] [Related]
33. Genetic variants modify susceptibility to leukemia in infants: a Children's Oncology Group report.
Ross JA; Linabery AM; Blommer CN; Langer EK; Spector LG; Hilden JM; Heerema NA; Radloff GA; Tower RL; Davies SM
Pediatr Blood Cancer; 2013 Jan; 60(1):31-4. PubMed ID: 22422485
[TBL] [Abstract][Full Text] [Related]
34. Confirmation of childhood acute lymphoblastic leukemia variants, ARID5B and IKZF1, and interaction with parental environmental exposures.
Evans TJ; Milne E; Anderson D; de Klerk NH; Jamieson SE; Talseth-Palmer BA; Bowden NA; Holliday EG; Rudant J; Orsi L; Richardson E; Lavis L; Catchpoole D; Attia JR; Armstrong BK; Clavel J; Scott RJ
PLoS One; 2014; 9(10):e110255. PubMed ID: 25310577
[TBL] [Abstract][Full Text] [Related]
35. Associations between AT-rich interactive domain 5B gene polymorphisms and risk of childhood acute lymphoblastic leukemia: a meta-analysis.
Zeng H; Wang XB; Cui NH; Nam S; Zeng T; Long X
Asian Pac J Cancer Prev; 2014; 15(15):6211-7. PubMed ID: 25124600
[TBL] [Abstract][Full Text] [Related]
36. [Polymorphism of Glutathione S-Transferases and Genetic Sensitivity of Childhood Acute Lymphoblastic Leukemia: A Meta-Analysis].
Zhang HY; Zhang J; Wu T; Bai H
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Feb; 25(1):16-23. PubMed ID: 28245369
[TBL] [Abstract][Full Text] [Related]
37. Novel insights into etiologies of leukemia: a HuGE review and meta-analysis of CYP1A1 polymorphisms and leukemia risk.
Han F; Tan Y; Cui W; Dong L; Li W
Am J Epidemiol; 2013 Aug; 178(4):493-507. PubMed ID: 23707957
[TBL] [Abstract][Full Text] [Related]
38. Xeroderma pigmentosum group D polymorphisms and esophageal cancer susceptibility: a meta-analysis based on case-control studies.
Yang R; Zhang C; Malik A; Shen ZD; Hu J; Wu YH
World J Gastroenterol; 2014 Nov; 20(44):16765-73. PubMed ID: 25469049
[TBL] [Abstract][Full Text] [Related]
39. Association of ARID5B and IKZF1 Variants with Leukemia from Northern India.
Bhat A; Shah R; Bhat GR; Verma S; Sharma V; Sharma I; Pandita M; Bakshi D; Sharma B; Suri J; Kumar R
Genet Test Mol Biomarkers; 2019 Mar; 23(3):176-179. PubMed ID: 30810385
[TBL] [Abstract][Full Text] [Related]
40. AdipoQ polymorphisms are associated with type 2 diabetes mellitus: a meta-analysis study.
Chu H; Wang M; Zhong D; Shi D; Ma L; Tong N; Zhang Z
Diabetes Metab Res Rev; 2013 Oct; 29(7):532-45. PubMed ID: 23653335
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
